Prediction of all-cause mortality for chronic kidney disease patients using four models of machine learning

Author:

Tran Nu Thuy Dung1,Balezeaux Margaux1,Granal Maelys1,Fouque Denis2ORCID,Ducher Michel3,Fauvel Jean-Pierre1

Affiliation:

1. UMR 5558 CNRS Lyon, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Hôpital Edouard Herriot, Service de Néphrologie, Lyon , France

2. Université Claude Bernard Lyon 1, Carmen, Dept Nephrology, Nutrition and Dialysis, Hôpital Lyon Sud, Hospices Civils de Lyon , Pierre-Benite , France

3. EMR3738 Ciblage thérapeutique en oncologie, Université Claude Bernard Lyon 1, Hospices Civils de Lyon , Pharmacie, Lyon , France

Abstract

ABSTRACT Background The prediction tools developed from general population data to predict all-cause mortality are not adapted to chronic kidney disease (CKD) patients, because this population displays a higher mortality risk. This study aimed to create a clinical prediction tool with good predictive performance to predict the 2-year all-cause mortality of stage 4 or stage 5 CKD patients. Methods The performance of four different models (deep learning, random forest, Bayesian network, logistic regression) to create four prediction tools was compared using a 10-fold cross validation. The model that offered the best performance for predicting mortality in the Photo-Graphe 3 cohort was selected and then optimized using synthetic data and a selected number of explanatory variables. The performance of the optimized prediction tool to correctly predict the 2-year mortality of the patients included in the Photo-Graphe 3 database were then assessed. Results Prediction tools developed using the Bayesian network and logistic regression tended to have the best performances. Although not significantly different from logistic regression, the prediction tool developed using the Bayesian network was chosen because of its advantages and then optimized. The optimized prediction tool that was developed using synthetic data and the seven variables with the best predictive value (age, erythropoietin-stimulating agent, cardiovascular history, smoking status, 25-hydroxy vitamin D, parathyroid hormone and ferritin levels) had satisfactory internal performance. Conclusions A Bayesian network was used to create a seven-variable prediction tool to predict the 2-year all-cause mortality in patients with stage 4–5 CKD. Prior to external validation, the proposed prediction tool can be used at: https://dev.hed.cc/?a=jpfauvel&n=2022-05%20Modele%20Bayesien%2020000%20Mortalite%207%20variables%20Naif%20Zou%20online(1).neta for research purposes.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Reference41 articles.

1. The number of comorbidities predicts renal outcomes in patients with stage 3-5 chronic kidney disease;Lee;J Clin Med,2018

2. The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study;Fraser;BMC Nephrol,2015

3. Multimorbidity in people with chronic kidney disease: implications for outcomes and treatment;Fraser;Curr Opin Nephrol Hypertens,2016

4. Association of multimorbidity with mortality and healthcare utilization in chronic kidney disease;Bowling;J Am Geriatr Soc,2017

5. Developing a framework for evidence-based grading and assessment of predictive tools for clinical decision support;Khalifa;BMC Med Inf Decis Making,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3